DIFFERENTIATIVE PROGRAMS OF LYMPHOID PROGENITOR CELLS
淋巴祖细胞的分化程序
基本信息
- 批准号:3169773
- 负责人:
- 金额:$ 20.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-04-01 至 1995-01-31
- 项目状态:已结题
- 来源:
- 关键词:Abelson leukemia virus B lymphocyte CD antigens DNA directed DNA polymerase SDS polyacrylamide gel electrophoresis acute lymphocytic leukemia autoradiography cell differentiation cell growth regulation clone cells cytokine disease /disorder model flow cytometry fluorescence microscopy gel electrophoresis gene expression gene rearrangement hematopoietic stem cells host neoplasm interaction human tissue immunofluorescence technique immunoglobulin genes immunoregulation leukocyte activation /transformation leukopoiesis lymphocytic leukemia membrane proteins molecular cloning molecular oncology monoclonal antibody neoplastic transformation neuropeptides neutrophil nucleic acid sequence oncogenes pediatric neoplasm /cancer peptidases polymerase chain reaction protein sequence receptor binding tissue /cell culture transforming virus
项目摘要
The major objective of this project is to study the cellular and molecular
events associated with the differentiation of normal and malignant human
lymphoid progenitor cells (LPC). The study will emphasize the clonal
expansion of progenitor cells in non-T, non-B acute lymphoblastic leukemia
(ALL), and their nonmalignant counterparts present in bone marrow (BM).
Emphasis will be placed on the use of three monoclonal antibodies recently
produced in our laboratory, designated BA-1, BA-2, and BA-3, that appear to
bind to normal and malignant LPC at various stages of lymphoid cell
development. Four specific aims have been or are being pursued: (1) A
large number of lymphohematopoietic cell sources have been analyzed to
determine the relationship between the aforementioned monoclonal antibodies
and two intracellular markers of LPC, i.e., terminal deoxynucleotidyl
transferase (TdT) and cytoplasmic IgM (CIgM). The cell populations were
assayed by single or double fluorochrome staining using fluorescent
microscopy and flow cytofluorimetry. The results of these studies, which
identified candidate lymphoid progenitor cells, have been published. (2)
The phorbol ester TPA has been used to study the induction of
differentiation in normal and malignant LPC. TPA-induced changes were
analyzed by immunofluorescence and biosynthetic labeling followed by
SDS-PAGE. We have attempted to determine if there is a sequential
(differentiation-linked?) expression of cell surface structures recognized
by monoclonal antibodies and their relationship to the intracellular
markers of LPC, i.e., TdT and CIgM. The results suggest that
acquisition/loss of certain markers may be consistent with
differentiation-linked events in lymphoid cell precursors. (3) Major
emphasis is currently placed on examining the function that cell surface
molecules gp40/BA-I, p24/BA-2, and gp100/CALLA/BA-3 subserve to the cells
on which they are expressed. (4) Of particular interest is our recent
observation that gp100/CALLA is strikingly decreased on the surface of
neutrophils from patients with severe thermal injuries. Since neutrophils
from these patients exhibit various dysfunctions (i.e., in hemotaxis), we
are examining the possible role of gp100/CALLA in neutrophil function. (4)
Studies are underway to clone the genes encoding gp40/BA-1, p24/BA-2, and
gp/100/CACCA/BA-3 using mouse L cell transfection and subtractive
hybridization. (LB)
该项目的主要目的是研究细胞和分子
与正常和恶性人的分化相关的事件
淋巴样祖细胞(LPC)。 该研究将强调克隆
非-T非-B急性淋巴细胞白血病中祖细胞的扩展
(全部)及其在骨髓(BM)中存在的非恶性对应物。
最近将重点放在三种单克隆抗体上
在我们的实验室中生产,指定为BA-1,BA-2和BA-3,似乎是
在淋巴样细胞的各个阶段与正常和恶性LPC结合
发展。 已经或正在追求四个具体目标:(1)
已经分析了大量的淋巴瘤性细胞来源
确定上述单克隆抗体之间的关系
LPC的两个细胞内标记,即末端脱氧核苷酸
转移酶(TDT)和细胞质IgM(CIGM)。 细胞群是
用荧光染色单或双荧光色素染色测定
显微镜和流式细胞荧光法。 这些研究的结果,
已确定的候选淋巴样祖细胞已发表。 (2)
凤凰酯TPA已用于研究诱导
正常和恶性LPC的分化。 TPA引起的变化是
通过免疫荧光和生物合成标记分析
SDS-PAGE。 我们试图确定是否有顺序
(分化连接?)识别的细胞表面结构的表达
通过单克隆抗体及其与细胞内的关系
LPC的标记,即TDT和CIGM。 结果表明
某些标记的获取/丢失可能与
淋巴样细胞前体中分化连接的事件。 (3)专业
目前重点放在检查细胞表面的功能上
分子GP40/BA-I,P24/BA-2和GP100/CARLA/BA-3对细胞进行介绍
他们在上面表达。 (4)特别感兴趣的是我们最近的
观察到gp100/calla在表面上大幅下降
严重热损伤患者的中性粒细胞。 由于中性粒细胞
从这些患者中表现出各种功能障碍(即在炎症中),我们
正在研究GP100/Calla在中性粒细胞功能中的可能作用。 (4)
正在进行的研究,以克隆编码GP40/BA-1,P24/BA-2和
GP/100/CACCA/BA-3使用小鼠L细胞转染和减法
杂交。 (磅)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tucker W LeBien其他文献
Tucker W LeBien的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tucker W LeBien', 18)}}的其他基金
HUMAN LEUKEMIA AND THE BONE MARROW MICROENVIRONMENT
人类白血病和骨髓微环境
- 批准号:
2837754 - 财政年份:1997
- 资助金额:
$ 20.66万 - 项目类别:
HUMAN LEUKEMIA AND THE BONE MARROW MICROENVIRONMENT
人类白血病和骨髓微环境
- 批准号:
6124490 - 财政年份:1997
- 资助金额:
$ 20.66万 - 项目类别:
HUMAN LEUKEMIA AND THE BONE MARROW MICROENVIRONMENT
人类白血病和骨髓微环境
- 批准号:
2446825 - 财政年份:1997
- 资助金额:
$ 20.66万 - 项目类别:
相似国自然基金
WDR68通过PRC1复合体增强H3K27ac修饰促进急性B淋巴细胞白血病发生的机制及预后价值研究
- 批准号:82302600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
阑尾B淋巴细胞对溃疡性结肠炎发生发展的始动和促进作用研究
- 批准号:82370537
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Hippo信号通路调控B淋巴细胞分化在狼疮肾炎中的作用与机制研究
- 批准号:82302023
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非典型蛋白激酶C在B淋巴细胞介导免疫应答中的作用机制研究
- 批准号:32300740
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ISG15+ B淋巴细胞通过与PD-1+CXCR5−CD4+ Th-CXCL13 T细胞相互作用介导三级淋巴结构的形成和成熟以促进复发转移鼻咽癌免疫联合抗血管治疗响应的作用及机制研究
- 批准号:82373258
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Deciphering the molecular control of intratumoral dendritic cells
破译瘤内树突状细胞的分子控制
- 批准号:
10331052 - 财政年份:2021
- 资助金额:
$ 20.66万 - 项目类别:
Deciphering the molecular control of intratumoral dendritic cells
破译瘤内树突状细胞的分子控制
- 批准号:
10559621 - 财政年份:2021
- 资助金额:
$ 20.66万 - 项目类别:
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and Cells
捕获的免疫糖蛋白和细胞的简化聚糖分析工作流程
- 批准号:
10227699 - 财政年份:2019
- 资助金额:
$ 20.66万 - 项目类别:
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and Cells
捕获的免疫糖蛋白和细胞的简化聚糖分析工作流程
- 批准号:
9980821 - 财政年份:2019
- 资助金额:
$ 20.66万 - 项目类别: